CN Patent

CN114929209A — 肌萎缩侧索硬化的治疗

Assigned to Amylyx Pharmaceuticals Inc · Expires 2022-08-19 · 4y expired

What this patent protects

本文提供了用于在受试者中治疗ALS的至少一种症状、减缓ALS疾病进展或减少受ALS影响的一种或多种身体功能恶化的方法和组合物。所述方法可以包括向受试者施用胆汁酸或其药用盐以及苯基丁酸盐化合物。

USPTO Abstract

本文提供了用于在受试者中治疗ALS的至少一种症状、减缓ALS疾病进展或减少受ALS影响的一种或多种身体功能恶化的方法和组合物。所述方法可以包括向受试者施用胆汁酸或其药用盐以及苯基丁酸盐化合物。

Drugs covered by this patent

Patent Metadata

Patent number
CN114929209A
Jurisdiction
CN
Classification
—
Expires
2022-08-19
Drug substance claim
No
Drug product claim
No
Assignee
Amylyx Pharmaceuticals Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.